EGAL GORSE, M.D.
Student in an Organized Health Care Education/Training Program in MINNEAPOLIS, Minnesota. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
EGAL GORSE, M.D. reported a CMS MIPS final score of 83.5331/100 — above the 83.1 national average — and filed 1,065 Medicare Part D claims in 2023.
- 83.5331/100
- MIPS score · +0 vs avg
- 1K
- Part D claims, 2023
- 83%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
EGAL GORSE, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
84 42nd percentile higher than 42% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about EGAL GORSE, M.D.?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Minnesota
How Student in an Organized Health Care Education/Training Program compares to other specialties among Minnesota providers
Student in an Organized Health Care Education/Training Program share within Minnesota
Student in an Organized Health Care Education/Training Program is one of the more visible NUCC categories in Minnesota
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
EGAL GORSE, M.D.'s 2023 MIPS final score plotted against the Student in an Organized Health Care Education/Training Program national average
- MIPS Final Score
- 83.5331/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Student in an Organized Health Care Education/Training Program) — 83.5331/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Student in an Organized Health Care Education/Training Program US NPIs
83.5331/100 MIPS final score — 0.4 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Student in an Organized Health Care Education/Training Program. Quality dim: 81.7967. Cost dim: 63.3136.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
EGAL GORSE, M.D. appears in the CMS NPPES registry as a Student in an Organized Health Care Education/Training Program provider holding M.D. credentials at 800 E 28TH ST STE 401, MINNEAPOLIS, MN, 55407, with a listed phone of (612) 775-5314. NPI 1124481536 was issued on 04/01/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GORSE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,065 prescription claims written by this provider, covering 215 Medicare beneficiaries and totaling roughly $1.4 million in drug spend, split 17% brand-name and 83% generic by claim count, with an opioid prescribing rate of 5.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 83.5331/100 for the 2023 performance year (Quality 81.7967, Cost 63.3136), compared with the national average of 83.1.
Student in an Organized Health Care Education/Training Program is a high-volume specialty nationwide, with 331,761 enrolled providers across 55 states and an average of 459 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1124481536 |
|---|---|
| Specialty | Student in an Organized Health Care Education/Training Program |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/01/2016 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm EGAL GORSE, M.D.'s current license status, disciplinary history, and board certifications with the Minnesota Board of Medical Practice in Minnesota before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where EGAL GORSE, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
17% brand-name claims vs 83% generic, on 1,065 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,612
- Total Day Supply
- 41,452
- Brand vs Generic
- 17% brand / 83% generic
- Brand Drug Cost
- $1.1M
- Generic Drug Cost
- $308K
- Opioid Claims
- 56 (5.3% rate)
- Antibiotic Claims
- 89
Patient Demographics
- Average Patient Age
- 74.0 years
- Avg HCC Risk Score
- 2.29
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 16, 65-74: 102, 75-84: 72, 85+: 25
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What EGAL GORSE, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Eliquis
Eliquis
78 claims
- Anastrozole
Anastrozole
66 claims
- Ondansetron Hcl
Ondansetron Hcl
65 claims
- Prochlorperazine M…
Prochlorperazine Maleate
59 claims
- Acyclovir
Acyclovir
50 claims
- Dexamethasone
Dexamethasone
49 claims
- Sulfamethoxazole-T…
Sulfamethoxazole-Trimethoprim
44 claims
- Prednisone
Prednisone
34 claims
| Drug | Claims |
|---|---|
| Eliquis Apixaban | 78 |
| Anastrozole | 66 |
| Ondansetron Hcl | 65 |
| Prochlorperazine Maleate | 59 |
| Acyclovir | 50 |
| Dexamethasone | 49 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 44 |
| Prednisone | 34 |
| Hydroxyurea | 32 |
| Xarelto Rivaroxaban | 31 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Student in an Organized Health Care Education/Training Program Overview
How EGAL GORSE, M.D. fits within the Student in an Organized Health Care Education/Training Program landscape nationally.
EGAL GORSE, M.D.'s 1,065 claims are above the specialty average of 459.
Nearby Student in an Organized Health Care Education/Training Program Providers in Minnesota
Other clinicians with the same primary specialty enrolled in Minnesota, drawn from the same CMS NPPES roster as GORSE.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Minnesota
Frequently Asked Questions
What is EGAL GORSE, M.D.'s specialty? ▼
How much does EGAL GORSE, M.D. prescribe under Medicare Part D? ▼
What is EGAL GORSE, M.D.'s Medicare quality score? ▼
Where is EGAL GORSE, M.D. located? ▼
What is EGAL GORSE, M.D.'s NPI number? ▼
Does EGAL GORSE, M.D. prescribe more brand-name or generic drugs? ▼
Does EGAL GORSE, M.D. prescribe opioids? ▼
How many Student in an Organized Health Care Education/Training Program providers are there in the US? ▼
What drugs does EGAL GORSE, M.D. prescribe most often? ▼
Does EGAL GORSE, M.D. accept Medicare? ▼
How can I verify EGAL GORSE, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology